Earnings History Data for BioMarin Pharmaceutical Inc. (BMRN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc. is a developer of carbohydrate enzyme therapies for debilitating, life-threatening, chronic genetic disorders and other diseases and conditions. The company completed a six-month evaluation of patients being treated with BioMarin's lead product, BM101, for the treatment of mucopolysaccharidosis-I, or MPS-I. Patients were treated with BM101 as part of a pivotal clinical trial completed to determine the safety and efficacy of the drug in humans.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
28-07-2021 AH 4:00 PM ET
(Jul 28)
BMRN BioMarin Pharmaceutical Inc. 14,140 0.23 0.05 0.07 BioMarin Pharmaceutical EPS beats by $0.18, beats on revenue
[7/28/2021 4:10 PM]
78.53 -0.20 
(-0.25%)
79.55 0.82 
(1.04%)
71.35 - 124.52 966,048 980,000 3,102
29-04-2021 AH 4:05 PM ET
(Apr 29)
BMRN BioMarin Pharmaceutical Inc. 14,820 0.29 0.07 0.38 BioMarin Pharmaceutical EPS beats by $0.19, beats on revenue
[4/29/2021 4:10 PM]
77.88 -2.30 
(-2.87%)
78.25 -1.93 
(-2.41%)
71.35 - 131.94 1,275,871 780,000 5,770
25-02-2021 AH 4:05 PM ET
(Feb 25)
BMRN BioMarin Pharmaceutical Inc. 14,910 -0.05 -0.06 0.09 BioMarin Pharmaceutical EPS beats by $0.29, beats on revenue
[2/25/2021 4:11 PM]
77.48 -4.28 
(-5.23%)
79.00 -2.76 
(-3.38%)
68.25 - 131.94 2,353,573 1,121,882 1,535
05-11-2020 AH 4:05 PM ET
(Nov 5)
BMRN BioMarin Pharmaceutical Inc. 13,170 0.29 -0.01 0.22 BioMarin Pharmaceutical EPS beats by $2.97, beats on revenue
[11/5/2020 4:13 PM]
76.73 1.68 
(2.24%)
74.44 -0.61 
(-0.81%)
68.25 - 131.94 1,854,769 1,503,365 17,514
04-08-2020 AH 4:00 PM ET
(Aug 4)
BMRN BioMarin Pharmaceutical Inc. 21,670 0.07 -0.10 -0.08 BioMarin Pharmaceutical EPS misses by $0.04, beats on revenue, expects FY20 GAAP profit
[8/4/2020 4:09 PM]
120.09 0.26 
(0.22%)
119.80 -0.03 
(-0.02%)
62.88 - 131.94 693,279 970,055 1,546